Citigroup’s CorMedix CRMD Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $520K | Buy |
66,228
+28,077
| +74% | +$222K | ﹤0.01% | 3877 |
|
|
2026
Q1 | $259K | Sell |
38,151
-10,694
| -22% | -$79K | ﹤0.01% | 3881 |
|
|
2025
Q4 | $568K | Buy |
48,845
+114
| +0.2% | +$1.26K | ﹤0.01% | 3508 |
|
|
2025
Q3 | $567K | Buy |
48,731
+14,921
| +44% | +$180K | ﹤0.01% | 3518 |
|
|
2025
Q2 | $417K | Sell |
33,810
-23,814
| -41% | -$263K | ﹤0.01% | 3737 |
|
|
2025
Q1 | $355K | Sell |
57,624
-5,745
| -9% | -$59.5K | ﹤0.01% | 3861 |
|
|
2024
Q4 | $513K | Buy |
63,369
+23,464
| +59% | +$234K | ﹤0.01% | 3806 |
|
|
2024
Q3 | $322K | Buy |
39,905
+27,680
| +226% | +$150K | ﹤0.01% | 4030 |
|
|
2024
Q2 | $52.9K | Buy |
12,225
+2,980
| +32% | +$15.1K | ﹤0.01% | 4545 |
|
|
2024
Q1 | $39.2K | Buy |
9,245
+1,520
| +20% | +$5.27K | ﹤0.01% | 4740 |
|
|
2023
Q4 | $29K | Buy |
7,725
+7,702
| +33,487% | +$26.5K | ﹤0.01% | 4825 |
|
|
2023
Q3 | $85 | Sell |
23
-16,944
| -100% | -$67.4K | ﹤0.01% | 5444 |
|
|
2023
Q2 | $67.3K | Buy |
+16,967
| New | +$83.9K | ﹤0.01% | 4468 |
|
|
2022
Q3 | – | Sell |
-386
| Closed | -$2K | – | 5895 |
|
|
2022
Q2 | $2K | Sell |
386
-1,239
| -76% | -$4.6K | ﹤0.01% | 5869 |
|
|
2022
Q1 | $9K | Sell |
1,625
-8,019
| -83% | -$36.7K | ﹤0.01% | 5571 |
|
|
2021
Q4 | $44K | Buy |
9,644
+5,327
| +123% | +$26.4K | ﹤0.01% | 5128 |
|
|
2021
Q3 | $20K | Buy |
4,317
+2,515
| +140% | +$14.6K | ﹤0.01% | 5231 |
|
|
2021
Q2 | $12K | Sell |
1,802
-2,633
| -59% | -$20.9K | ﹤0.01% | 5565 |
|
|
2021
Q1 | $44K | Sell |
4,435
-1,408
| -24% | -$14.8K | ﹤0.01% | 4763 |
|
|
2020
Q4 | $43K | Buy |
5,843
+4,363
| +295% | +$29.7K | ﹤0.01% | 6139 |
|
|
2020
Q3 | $9K | Sell |
1,480
-2,004
| -58% | -$10.1K | ﹤0.01% | 6679 |
|
|
2020
Q2 | $22K | Sell |
3,484
-4,054
| -54% | -$18.8K | ﹤0.01% | 6534 |
|
|
2020
Q1 | $27K | Buy |
7,538
+2,388
| +46% | +$13.5K | ﹤0.01% | 6473 |
|
|
2019
Q4 | $37K | Buy |
5,150
+3,982
| +341% | +$24.3K | ﹤0.01% | 6552 |
|
|
2019
Q3 | $8K | Sell |
1,168
-5,435
| -82% | -$45.7K | ﹤0.01% | 7167 |
|
|
2019
Q2 | $59K | Buy |
+6,603
| New | +$51.8K | ﹤0.01% | 6316 |
|
|
2016
Q3 | – | Sell |
-10
| Closed | – | – | 7069 |
|
|
2016
Q2 | $0 | Sell |
10
-5,966
| -100% | -$90.9K | ﹤0.01% | 7115 |
|
|
2016
Q1 | $79K | Buy |
5,976
+3,912
| +190% | +$38K | ﹤0.01% | 5835 |
|
|
2015
Q4 | $21K | Buy |
2,064
+2,063
| +206,300% | +$23.8K | ﹤0.01% | 6455 |
|
|
2015
Q3 | $0 | Sell |
1
-80
| -99% | -$1.23K | ﹤0.01% | 7419 |
|
|
2015
Q2 | $2K | Buy |
+81
| New | +$2.78K | ﹤0.01% | 7114 |
|
|
2015
Q1 | – | Sell |
-51
| Closed | – | – | 7223 |
|
|
2014
Q4 | $0 | Sell |
51
-10
| -16% | -$80 | ﹤0.01% | 7130 |
|
|
2014
Q3 | $1K | Sell |
61
-499
| -89% | -$4.76K | ﹤0.01% | 6891 |
|
|
2014
Q2 | $5K | Buy |
560
+555
| +11,100% | +$4.73K | ﹤0.01% | 6448 |
|
|
2014
Q1 | $0 | Buy |
+5
| New | +$59 | ﹤0.01% | 7035 |
|
|
2013
Q3 | – | Sell |
-22
| Closed | – | – | 6816 |
|
|
2013
Q2 | $0 | Buy |
+22
| New | +$79 | ﹤0.01% | 6746 |
|
Other funds holding CRMD
DTC
RA
OAM
Citigroup's CRMD Position: Q2 2026 in Review
Citigroup increased its CorMedix (CRMD) stake by 74% in Q2 2026, buying an estimated $222K and bringing the position to 66,228 shares worth $520K. The position accounts for ﹤0.01% of the portfolio, ranked #3877.
Citigroup first reported a position in CRMD in Q2 2013 and has held it in 36 quarters since. The position peaked at $568K in Q4 2025. 194 funds tracked by Wall St. Rank hold CRMD as of Q2 2026.
- Citigroup held 66,228 shares of CorMedix worth $520K as of Q2 2026.
- Citigroup bought 28,077 CorMedix shares in Q2 2026, an estimated $222K.
- CorMedix made up ﹤0.01% of Citigroup's portfolio in Q2 2026, its #3877 holding.
- Citigroup first reported a position in CorMedix in Q2 2013 and has held it in 36 quarters since.
- Citigroup's CorMedix position peaked at $568K in Q4 2025.
- 194 funds tracked by Wall St. Rank held CorMedix as of Q2 2026.
Based on Citigroup's 13F filing for Q2 2026, filed 3 Aug 2026.